University

Cambridge Enterprise, Cambridge Innovation Capital and University of Cambridge are joined by 100 signatories like AstraZeneca and Microsoft for the Innovate Cambridge initiative.

Rice University has found its inaugural vice-president for innovation in Paul Cherukuri, currently executive director of its Institute of Biosciences and Bioengineering.

Mary Albertson is the new director for Georgia Tech’s Office of Technology Licensing, joining from University of Utah’s Pivot Center.

Oxford Science Enterprises now has just over $1bn under management and already boasts a portfolio of more than 80 University of Oxford spinouts.

Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.

Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.

The new Berkeley Frontier Fund reinvents the venture capital model by building in donations to University of California, Berkeley.

Ascenion and Goethe University Frankfurt are among the initiators of Carma Fund I, which will help start up and fund early life science projects.